Atlas Trials

Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects

Clinical trial NCT01473953 · COMPLETED

Trial details

NCT number
NCT01473953
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 2Healthy
Start date
2011-10-01
Primary completion
2012-03-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.